BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28868833)

  • 1. Evaluation of Interleukin-17 and Interleukin-23 in Pterygium: Immunohistochemistry Study.
    Tiong KI; Mohd Zahidin AZ; Sumugam SKA; Uchang J; Mohd Isa HD
    Asia Pac J Ophthalmol (Phila); 2017; 6(5):403-406. PubMed ID: 28868833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The abnormal expression of interleukine-1 family in pterygium].
    Wen Z; Liu Z
    Yan Ke Xue Bao; 2003 Jun; 19(2):133-6. PubMed ID: 12870354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva.
    Liang K; Jiang Z; Ding BQ; Cheng P; Huang DK; Tao LM
    Mol Vis; 2011; 17():1687-93. PubMed ID: 21738398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claudin-1 expressions decrease in pterygium with respect to normal conjunctiva.
    Dogan AS; Onder E; Arikok AT; Bicer T; Gurdal C
    Cutan Ocul Toxicol; 2016 Dec; 35(4):315-8. PubMed ID: 26820697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of vimentin-expressing cells in pterygium: an immunocytochemical study of impression cytology specimens.
    Chen YT; Tseng SH; Tsai YY; Huang FC; Tseng SY
    Cornea; 2009 Jun; 28(5):547-52. PubMed ID: 19421041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17 and its correlation with vascular endothelial growth factor expression in ocular surface pathologies: a histologic study.
    Jabarin B; Solomon A; Amer R
    Eur J Ophthalmol; 2016 Jun; 26(4):283-6. PubMed ID: 26615952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p63 in pterygium and normal conjunctiva.
    Sakoonwatanyoo P; Tan DT; Smith DR
    Cornea; 2004 Jan; 23(1):67-70. PubMed ID: 14701960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ηypoxia-inducible factor-1α, von Hippel-Lindau protein, and heat shock protein expression in ophthalmic pterygium and normal conjunctiva.
    Pagoulatos D; Pharmakakis N; Lakoumentas J; Assimakopoulou M
    Mol Vis; 2014; 20():441-57. PubMed ID: 24715760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of Hsp90 and Ki-67 in pterygium.
    Sebastiá R; Ventura MP; Solari HP; Antecka E; Orellana ME; Burnier MN
    Diagn Pathol; 2013 Feb; 8():32. PubMed ID: 23432803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of prostaglandin E
    Dinç E; Dursun Ö; Yılmaz B; Vatansever M; Sarı AA; Yıldırım Ö; Adıgüzel U
    Int Ophthalmol; 2018 Aug; 38(4):1703-1708. PubMed ID: 28695379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-expression of human cystatin C in pterygium versus healthy conjunctiva.
    Barba-Gallardo LF; Ventura-Juárez J; Kershenobich Stalnikowitz D; Gutiérrez-Campos R; Torres-Bernal E; Torres-Bernal LF
    BMC Ophthalmol; 2013 Feb; 13():6. PubMed ID: 23442876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2, p53, and Ki-67 expression in pterygium and normal conjunctiva and their relationship with pterygium recurrence.
    Turan M; Turan G
    Eur J Ophthalmol; 2020 Nov; 30(6):1232-1237. PubMed ID: 32703006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics analysis in pterygium tissue.
    Saglik A; Koyuncu I; Gonel A; Yalcin H; Adibelli FM; Toptan M
    Int Ophthalmol; 2019 Oct; 39(10):2325-2333. PubMed ID: 30617855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YKL-40 expression in pterygium: a potential role in the pathogenesis.
    Kurt A; Kılıç R; Tad M; Polat OA
    Int Ophthalmol; 2019 Jul; 39(7):1445-1450. PubMed ID: 29922975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRP3 and NLRP6 expression in pterygium and normal conjunctiva and their relationship with pterygium formation and recurrence.
    Guo Z; Wang Y; Wang L; Li Q; Yuan X; Hua X
    Eur J Ophthalmol; 2022 Sep; 32(5):3058-3063. PubMed ID: 35068231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of fractalkine and its histopathological characteristics in primary pterygium.
    Turan M; Turan G
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2743-2750. PubMed ID: 31637486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic characterization of telocyte-like cells in pterygium.
    Maxia C; Murtas D; Isola M; Tamma R; Zucca I; Piras F; Ribatti D; Diana A; Perra MT
    Mol Vis; 2018; 24():853-866. PubMed ID: 30713424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated blood/lymphatic vessel ratio in pterygium and its relationship with vascular endothelial growth factor (VEGF) distribution.
    Martín-López J; Pérez-Rico C; García-Honduvilla N; Buján J; Pascual G
    Histol Histopathol; 2019 Aug; 34(8):917-929. PubMed ID: 30821336
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Dong S; Wu X; Xu Y; Yang G; Yan M
    Mol Vis; 2020; 26():510-516. PubMed ID: 32753832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of c-Myc in pterygium and cultured pterygial cells.
    Cui D; Pan Z; Zhang S; Zheng J; Huang Q; Wu K
    Clin Exp Ophthalmol; 2011 Nov; 39(8):784-92. PubMed ID: 22050566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.